Cargando…
Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3
PURPOSE: In our previous study, we found that AKR1C3 was a radioresistance gene in KY170R cells. Downregulating the expression of AKR1C3 could enhance the radiosensitivity of esophageal carcinoma cells. In this study, we investigated whether methyl jasmonate (MeJ), an inhibitor of Aldo-keto reductas...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124458/ https://www.ncbi.nlm.nih.gov/pubmed/30214307 http://dx.doi.org/10.2147/CMAR.S166942 |
_version_ | 1783353030504087552 |
---|---|
author | Li, Xiaoying Hong, Xin Gao, Xianshu Gu, Xiaobin Xiong, Wei Zhao, Jing Yu, Hongliang Cui, Ming Xie, Mu Bai, Yun Sun, Shaoqian |
author_facet | Li, Xiaoying Hong, Xin Gao, Xianshu Gu, Xiaobin Xiong, Wei Zhao, Jing Yu, Hongliang Cui, Ming Xie, Mu Bai, Yun Sun, Shaoqian |
author_sort | Li, Xiaoying |
collection | PubMed |
description | PURPOSE: In our previous study, we found that AKR1C3 was a radioresistance gene in KY170R cells. Downregulating the expression of AKR1C3 could enhance the radiosensitivity of esophageal carcinoma cells. In this study, we investigated whether methyl jasmonate (MeJ), an inhibitor of Aldo-keto reductase family1 member C3 (AKR1C3), could overcome radiation resistance in AKR1C3 highly expressed cells. PATIENTS AND METHODS: We used clone formation assays to detect radiosensitivity effects. Flow cytometry assays were used to detect reactive oxygen species (ROS) accumulation and apoptosis. Enzyme linked immunosorbent assays (ELISAs) were used to detect the concentrations of prostaglandin F2 (PGF2) and prostaglandin D2 (PGD2) in the cells after incubation with MeJ. Western blotting was used to detect AKR1C3 and peroxisome proliferator-activated receptor gamma (PPARγ) expression. RESULTS: We found that AKR1C3 was highly expressed in radioresistant esophageal carcinoma cells. MeJ inhibited the expression of AKR1C3 and enhanced the radiation sensitivity of esophageal carcinoma cells expressing high levels of AKR1C3 (P<0.05). MeJ could inhibit the 11-ketoprostaglandin reductase activity of AKR1C3 in a dose-dependent manner in KY170R cells. Incubation of KY170R cells with 200 µmol/L of MeJ for 24 h reduced the expression of PGF2 by roughly 30% (P<0.05). The PPAR pathway inhibitor GW9662 prevented the radiation sensitivity enhancement imparted by MeJ. After adding GW9662, there were no significant differences between the radiation sensitivities of MeJ-treated and -untreated KY170R cells (P>0.05). The radiation sensitivity effect of MeJ also depended upon the generation of ROS in KY170R cells; 48 h after irradiation, ROS levels in the MeJ group was twofold higher than in the untreated KY170R cells (P<0.05). The ROS scavenger, N-acetyl cysteine, could reverse the radiosensitivity effects of MeJ (P>0.05). CONCLUSION: Our results indicate that MeJ can increase the radiation sensitivity of AKR1C3-overexpressing KY170R cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 and increasing cellular ROS levels. |
format | Online Article Text |
id | pubmed-6124458 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-61244582018-09-13 Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 Li, Xiaoying Hong, Xin Gao, Xianshu Gu, Xiaobin Xiong, Wei Zhao, Jing Yu, Hongliang Cui, Ming Xie, Mu Bai, Yun Sun, Shaoqian Cancer Manag Res Original Research PURPOSE: In our previous study, we found that AKR1C3 was a radioresistance gene in KY170R cells. Downregulating the expression of AKR1C3 could enhance the radiosensitivity of esophageal carcinoma cells. In this study, we investigated whether methyl jasmonate (MeJ), an inhibitor of Aldo-keto reductase family1 member C3 (AKR1C3), could overcome radiation resistance in AKR1C3 highly expressed cells. PATIENTS AND METHODS: We used clone formation assays to detect radiosensitivity effects. Flow cytometry assays were used to detect reactive oxygen species (ROS) accumulation and apoptosis. Enzyme linked immunosorbent assays (ELISAs) were used to detect the concentrations of prostaglandin F2 (PGF2) and prostaglandin D2 (PGD2) in the cells after incubation with MeJ. Western blotting was used to detect AKR1C3 and peroxisome proliferator-activated receptor gamma (PPARγ) expression. RESULTS: We found that AKR1C3 was highly expressed in radioresistant esophageal carcinoma cells. MeJ inhibited the expression of AKR1C3 and enhanced the radiation sensitivity of esophageal carcinoma cells expressing high levels of AKR1C3 (P<0.05). MeJ could inhibit the 11-ketoprostaglandin reductase activity of AKR1C3 in a dose-dependent manner in KY170R cells. Incubation of KY170R cells with 200 µmol/L of MeJ for 24 h reduced the expression of PGF2 by roughly 30% (P<0.05). The PPAR pathway inhibitor GW9662 prevented the radiation sensitivity enhancement imparted by MeJ. After adding GW9662, there were no significant differences between the radiation sensitivities of MeJ-treated and -untreated KY170R cells (P>0.05). The radiation sensitivity effect of MeJ also depended upon the generation of ROS in KY170R cells; 48 h after irradiation, ROS levels in the MeJ group was twofold higher than in the untreated KY170R cells (P<0.05). The ROS scavenger, N-acetyl cysteine, could reverse the radiosensitivity effects of MeJ (P>0.05). CONCLUSION: Our results indicate that MeJ can increase the radiation sensitivity of AKR1C3-overexpressing KY170R cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 and increasing cellular ROS levels. Dove Medical Press 2018-08-31 /pmc/articles/PMC6124458/ /pubmed/30214307 http://dx.doi.org/10.2147/CMAR.S166942 Text en © 2018 Li et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Li, Xiaoying Hong, Xin Gao, Xianshu Gu, Xiaobin Xiong, Wei Zhao, Jing Yu, Hongliang Cui, Ming Xie, Mu Bai, Yun Sun, Shaoqian Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 |
title | Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 |
title_full | Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 |
title_fullStr | Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 |
title_full_unstemmed | Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 |
title_short | Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 |
title_sort | methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of akr1c3 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124458/ https://www.ncbi.nlm.nih.gov/pubmed/30214307 http://dx.doi.org/10.2147/CMAR.S166942 |
work_keys_str_mv | AT lixiaoying methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3 AT hongxin methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3 AT gaoxianshu methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3 AT guxiaobin methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3 AT xiongwei methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3 AT zhaojing methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3 AT yuhongliang methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3 AT cuiming methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3 AT xiemu methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3 AT baiyun methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3 AT sunshaoqian methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3 |